CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sichuan Languang Development Co Ltd Company Snapshot
Sichuan Languang Development Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sichuan Languang Development Co Ltd with three other companies in this sector in China: Nanjing Pharmaceutical Company Limited (2017 sales of 27.47 billion Chinese Renmimbi [US$4.00 billion] of which 95% was Wholesale Business), Shenzhen Neptunus Bioengineer (24.94 billion Chinese Renmimbi [US$3.63 billion] of which 78% was Pharmaceutical Distribution), and Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd (20.95 billion Chinese Renmimbi [US$3.05 billion] of which 41% was Health).

Sales Analysis. Sichuan Languang Development Co Ltd reported sales of 23.19 billion Chinese Renmimbi (US$3.38 billion) for the year ending December of 2017. This represents an increase of 16.2% versus 2016, when the company's sales were 19.95 billion Chinese Renmimbi. Sales at Sichuan Languang Development Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 6,271%). Sales of Modern Service saw an increase that was more than double the company's growth rate: sales were up 42.9% in 2017, from 680.11 million Chinese Renmimbi to 971.94 million Chinese Renmimbi. Sichuan Languang Development Co Ltd also saw significant increases in sales in Pharmaceutical Sale (up 40.9% to 782.08 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sichuan Languang Development Co Ltd
  Stock Performance Chart for Sichuan Languang Development Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/14/2018): 5.03
(Figures in Chinese Renmimbi)
1 Week -3.8%   13 Weeks -7.4%  
4 Weeks -27.0%   52 Weeks -31.9%  
 
Sichuan Languang Development Co Ltd Key Data:
  Ticker: 600466 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 23,192,961,744
(Year Ending Jan 2018).
Employees: 14,635
  Currency: Chinese Renmimbi Market Cap: 14,954,623,641
  Fiscal Yr Ends: December Shares Outstanding: 2,973,086,211
  Share Type: A Gu Closely Held Shares: 1,833,210,616
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.